Clinical Trials Directory

Trials / Conditions / Non-obstructive Hypertrophic Cardiomyopathy

Non-obstructive Hypertrophic Cardiomyopathy

9 registered clinical trials studyying Non-obstructive Hypertrophic Cardiomyopathy — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hype
NCT07023614
Imbria Pharmaceuticals, Inc.Phase 2
TerminatedEffect of Personalized Accelerated Pacing in Symptomatic Patients With Non-Obstructive Hypertrophic Cardiomyop
NCT06775886
Montefiore Medical CenterN/A
RecruitingA Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy
NCT06816251
Shandong Suncadia Medicine Co., Ltd.Phase 2
RecruitingA Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hy
NCT06481891
Lexicon PharmaceuticalsPhase 3
RecruitingTreatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardio
NCT05569382
Morten Steen Kvistholm JensenPhase 4
CompletedA Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hyp
NCT04826185
Imbria Pharmaceuticals, Inc.Phase 2
CompletedA Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM
NCT03723655
Bristol-Myers SquibbPhase 2 / Phase 3
CompletedA Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)
NCT03442764
MyoKardia, Inc.Phase 2
CompletedEffects of Continous Positive Airway Pressure (CPAP) in Hypertrophic Cardiomyopathy
NCT01631006
University of Sao PauloN/A